Update on non–acquired immunodeficiency syndrome–defining malignancies

@article{Chiao2003UpdateON,
  title={Update on non–acquired immunodeficiency syndrome–defining malignancies},
  author={E. Chiao and S. Krown},
  journal={Current Opinion in Oncology},
  year={2003},
  volume={15},
  pages={389-397}
}
Purpose of review Since the introduction of highly active antiretroviral therapy (HAART), the natural history of human immunodeficiency virus (HIV) infection has changed. Early in the acquired immunodeficiency syndrome (AIDS) epidemic, epidemiologic studies showed that HIV-infected patients were at higher risk for developing specific AIDS-defining malignancies. More recent studies linking HIV/AIDS databases to cancer registries have shown that HIV-infected patients are also at higher risk of… Expand
The growing problem of non-AIDS-defining malignancies in HIV
TLDR
It is unclear whether the growing number of reports on non-AIDS-defining cancers reflects a true increased incidence or merely the product of increased surveillance, detection and reporting. Expand
Current treatment strategies for patients with Hodgkin’s lymphoma and HIV infection
TLDR
The improved control of HIV infection and the subsequently improved survival rates of HIV-infected patients has changed the goal from tumor control to cure and new treatment approaches with more potent regimens need to be evaluated to improve survival and quality of life in HIV-HL. Expand
Noninfectious pulmonary complications of HIV/AIDS
  • G. Kanmogne
  • Medicine
  • Current opinion in pulmonary medicine
  • 2005
TLDR
The beneficial effect of HAART and improved immune response on the treatment of Kaposi sarcoma and AIDS-related lymphoma suggests that HIV or viral-induced immunosuppression plays an important role in the development of these malignancies. Expand
Non – AIDS-Defi ning Malignancies in HIV
  • 2008
The incidence of non–AIDS-defi ning cancers (NADCs) has increased by greater than 3-fold over the past 10 years and has now surpassed that of AIDS-defi ning cancers (ADCs) in HIVinfected patients.Expand
Non-AIDS Defining Malignancies Become an Emerging Problem in HIV-Infected Patients: At a Glance on Oral Pathology Unit, University of Dental Medicine (Yangon)
TLDR
Surgical pathology cases with HIV infection those sent to Oral Pathology Unit, University of Dental Medicine, Yangon, from January 2013 to November 2015 are observed and NADC is found to be an emerging problem in HIVinfected patients. Expand
A patient with a 12-year history characterized by four non-AIDS-related malignancies, occurring before and after the disclosure of HIV infection
TLDR
A unique case of HIV infection detected after two non-AIDS defining malignancies concurrently with a syphilis with an atypical cutaneous picture is reported, complicated by two further non- AIDS defining cancers occurring in an overall 12-year period. Expand
Breast cancer in women with human immunodeficiency virus infection: pathological, clinical, and prognostic implications.
TLDR
It is demonstrated that histological subgroups and 5-year survival appear similar among HIV-positive breast cancer patients and the finding that HIV infection in premenopausal women was not associated with aggressive breast cancer subtypes with poor survival outcome. Expand
Malignancies in HIV‐infected Thai patients *
TLDR
Of 1416 HIV‐infected patients seen at Ramathibodi Hospital over a 5‐year period (1999–2003), 42 were diagnosed with malignancies, giving a prevalence of 3%, and the 75% survival time of patients who received treatment for their malignancy was longer than that of Patients who received no treatment. Expand
Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors
TLDR
The spectrum of cancer diagnoses in the Asia region currently does not appear dissimilar to that observed in non-Asian HIV populations, and one interesting finding was the cases of leiomyosarcoma, a smooth-muscle tumour usually seen in children and young adults with AIDS, yet overall quite rare. Expand
HIV-1, AIDS, and Related Malignancies
TLDR
Increased survival among HIV-1 infected adults and children could lead to an increase in malignancies owing to chronic immune suppression, coinfection by oncogenic viruses, and/or persistent HIV- 1 infection. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 90 REFERENCES
Oncological complications of human immunodeficiency virus disease and hematologic consequences of their treatment.
  • R. Mitsuyasu
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 1999
TLDR
Chemotherapy for virus-related tumors in patients with HIV-induced immune deficiency can result in dose-limiting cytopenia that can be well-controlled with hematopoietic growth factors, allowing patients to avoid transfusions and maintain the dose intensity of their chemotherapy regimens. Expand
Association of cancer with AIDS-related immunosuppression in adults.
TLDR
Although occurring in overall excess, most non-AIDS-defining cancers do not appear to be influenced by the advancing immunosuppression associated with HIV disease progression. Expand
Pathogenesis of non-AIDS-defining cancers: a review.
TLDR
It is suggested that wide-spread genomic instability, as manifested by the development of increased numbers of microsatellite alterations (MAs), may occur frequently in HIV-associated tumors and they may play an important role in the pathogenesis of those neoplasms. Expand
AIDS and non-AIDS-related malignancies: a new vexing challenge in HIV-positive patients. Part II. Cervical and anal squamous epithelial lesions, lung cancer, testicular germ cell cancers, and skin cancers.
TLDR
Physicians who treat patients with AIDS and non-AIDS-related cancers need to become familiar with antiretroviral agents, drug-drug interactions, and the prophylaxis and management of opportunistic infections. Expand
HIV-related lung cancer in the era of highly active antiretroviral therapy
TLDR
HIV-related lung cancer occurred more frequently in the post-HAART era, when compared with the HIV-negative population, and the outcome of these patients remains poor despite HAART. Expand
The spectrum of HIV‐1 related cancers in South Africa
TLDR
In Johannesburg, South Africa, HIV infection was associated with significantly increased risks of Kaposi's sarcoma, non‐Hodgkin lymphoma and cancers of the cervix and the vulva, which were substantially lower than those found in the West. Expand
Lung cancer in patients with HIV-infection.
TLDR
Lung cancer in HIV-seropositive patients is characterized by a younger age at time of diagnosis when compared to HIV-indeterminate cases; the majority of cases occur in a background of extensive cigarette smoking; over 80% of patients present with advanced stage of lung cancer (stage III and IV); up to 50% of cases have asymptomatic to mildly symptomatic HIV infection with a median CD4 lymphocyte count of 233 per microliter. Expand
Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects.
TLDR
Microsatellite alterations, which reflect widespread genomic instability, occur at greatly increased frequency in HIV-associated lung carcinomas, and may play a crucial role in the development of many HIV- associated tumors. Expand
Malignant plasma cell tumors in human immunodeficiency virus‐infected patients
TLDR
The authors describe two cases of malignant plasma cell tumors in two young HIV‐infected patients and the finding of another manifestation of B‐cell neoplasia in these patients may enlarge the spectrum of AIDS‐related tumors. Expand
Lung cancer in patients with human immunodeficiency virus infection compared with historic control subjects.
TLDR
This retrospective case-control study compared 19 patients with both pathologically verified lung cancer and HIV infection proved by serologic study with lung cancer patients with an indeterminate HIV status to determine if there were differences in age, sex, and stage distribution and in survival between HIV-positive and HIV-indeterminate lung cancer Patients. Expand
...
1
2
3
4
5
...